Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Fabio Guolo, MD, Paola Minetto, MD, Giordana Pastori, MD, Livia Giannoni, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Francesco Trovato, MD, Marcella Bado, MD, Filippo Ballerini, MD, Marino Clavio, MD, Barbara Rebesco, MD, Maurizio Miglino, PhD, Andrea Bacigalupo, MD, Marco Gobbi, MD, Roberto Lemoli, MD

Blood (2014) 124 (21): 2266.

https://doi.org/10.1182/blood.V124.21.2266.2266

Published: 2014

Journal Articles

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Laura Mitscheunig, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Enrico De Astis, MD, Daniele Avenoso, MD, Livia Giannoni, MD, Giordana Pastori, MD, Lisette Del Corso, MD, Enrico Balleari, MD, Filippo Ballerini, MD, Roberto Lemoli, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2014) 124 (21): 5603.

https://doi.org/10.1182/blood.V124.21.5603.5603

Published: 2014

Journal Articles

Posaconazole for Primary Antifungal Prophylaxis in AML Patients: A Real Life Single Center Experience and a Comparison with the Historical Cohort

Paola Minetto, MD, Fabio Guolo, MD, Malgorzata Mikulska, MD, Giordana Pastori, MD, Livia Giannoni, MD, Elisa Furfaro, Franca Miletich, Valerio Del Bono, MD, Filippo Ballerini, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Claudio Viscoli, MD, Marco Gobbi, MD

Blood (2014) 124 (21): 5255.

https://doi.org/10.1182/blood.V124.21.5255.5255

Published: 2014

Journal Articles

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Livia Giannoni, MD, Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Chiara Ghiggi, MD, Marino Clavio, MD, Samuele Bagnasco, MD, Carmen Di Grazia, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Daniele Avenoso, MD, Giordana Pastori, MD, Filippo Ballerini, MD, Annalisa Kunkl, PhD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2014) 124 (21): 1027.

https://doi.org/10.1182/blood.V124.21.1027.1027

Published: 2014

Journal Articles

Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma

Micaela Bergamaschi, MD, Laura Mitscheunig, Fabio Guolo, MD, Anna Ghiso, Federica Galaverna, Maurizio Miglino, PHD, Marino Clavio, MD, Filippo Ballerini, PHD, Letizia Canepa, MD, Roberto Lemoli, Marco Gobbi, MD, Ivana Pierri, MD

Blood (2013) 122 (21): 5095.

https://doi.org/10.1182/blood.V122.21.5095.5095

Published: 2013

Journal Articles

Proteomic Profile Of CD34+ Cells From Chronic Myeloid Leukemia Patients and From Normal Donors

Maria Rosaria Ricciardi, Valentina Salvestrini, Mattia Forcato, Roberto Licchetta, Simone Mirabilii, Lara Rossi, Matteo Allegretti, Martina Vincenzi, Simona Salati, Phd, Fausto Castagnetti, Gianantonio Rosti, Giuliana Alimena, Rossella Manfredini, PhD, Silvio Bicciato, PhD, Roberto Lemoli, Agostino Tafuri

Blood (2013) 122 (21): 2712.

https://doi.org/10.1182/blood.V122.21.2712.2712

Published: 2013

Journal Articles

How We Treat Chronic Myeloid Leukemia Patients During Daily Practice? Case Studies From The Real Life Experience Of Two Genoa Centers Of Hematology

Laura Mitscheunig, Micaela Bergamaschi, MD, Raffalla Grosso, Maurizio Miglino, PHD, Marino Clavio, MD, Filippo Ballerini, PHD, Letizia Canepa, MD, Riccardo Varaldo, Roberto Lemoli, Marco Gobbi, MD, Ivana Pierri, MD

Blood (2013) 122 (21): 5192.

https://doi.org/10.1182/blood.V122.21.5192.5192

Published: 2013

Journal Articles

Impaired Interaction Between Regulatory T Cells and Dendritic Cells in Immune Thrombocytopenia.

Lucia Catani, Daria Sollazzo, Antonio Curti, Sara Trabanelli, Francesca Palandri, Nicola Polverelli, Michele Baccarani, Nicola Vianelli, Roberto Lemoli

Blood (2009) 114 (22): 3511.

https://doi.org/10.1182/blood.V114.22.3511.3511

Published: 2009

NARROW

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Posaconazole for Primary Antifungal Prophylaxis in AML Patients: A Real Life Single Center Experience and a Comparison with the Historical Cohort

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma

Proteomic Profile Of CD34+ Cells From Chronic Myeloid Leukemia Patients and From Normal Donors

How We Treat Chronic Myeloid Leukemia Patients During Daily Practice? Case Studies From The Real Life Experience Of Two Genoa Centers Of Hematology

Impaired Interaction Between Regulatory T Cells and Dendritic Cells in Immune Thrombocytopenia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only